A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer metabolism by controlling the powerful mTOR growth pathway, tying survival and energy use together. This insight explains why MCL1-targeting drugs can be effective—but also why they sometimes damage the heart. Researchers have now identified a way to reduce that risk, potentially unlocking safer cancer therapies.
source https://www.sciencedaily.com/releases/2026/01/260104202819.htm
Your handheld PC might soon play old PlayStation 3 games better — here's
why developers want your help
-
RPCS3 is asking handheld PC users for feedback as it works on improving the
portable experience for its PlayStation 3 emulator. Planned updates include
a r...
17 hours ago
No comments:
Post a Comment